The role of pleural fluid thiol/disulphide homoeostasis in the differentiation between transudative and exudative pleural effusions
Objective In the present study, we aimed to differentiate between transudative and exudative pleural effusions using thiol sulphide homoeostasis, an oxidative stress marker. Design This was a prospective study. Setting Emergency Department of Ankara City Hospital, between 1 January 2020 and 15 May 2...
Gespeichert in:
Veröffentlicht in: | International journal of clinical practice (Esher) 2021-04, Vol.75 (4), p.e14051-n/a |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective
In the present study, we aimed to differentiate between transudative and exudative pleural effusions using thiol sulphide homoeostasis, an oxidative stress marker.
Design
This was a prospective study.
Setting
Emergency Department of Ankara City Hospital, between 1 January 2020 and 15 May 2020.
Subjects
Patients who were diagnosed with pleural effusion and underwent thoracentesis to make a differentiation between transudative and exudative pleural effusions. The patients were divided into two groups as those who have transudative pleural effusion and those who have exudative pleural effusion. These two groups were assessed with respect to demographic features and oxidative stress parameters.
Main Outcome Measures
Oxidative stress parameters (The native thiol (NT), total thiol (TT), and disulphide (D) levels and their ratios to one another were calculated (index 1: D/NT, index 2:D/TT, index 3: NT/TT).
Results
This study enrolled a total of 50 patients with pleural effusion. Twenty patients (40%) were men, and 30 patients (60%) were women. In the transudative pleural effusion group, 14 patients (56%) had decompensated heart failure, 9 patients (36%) had hepatic cirrhosis, and 2 patients (8%) had hypoalbuminemia. In the exudative pleural effusion group, 17 patients (68%) had malignancy, 7 patients (28%) had parapneumonic effusion, and 1 patient (4%) had pulmonary embolism. TT (P |
---|---|
ISSN: | 1368-5031 1742-1241 |
DOI: | 10.1111/ijcp.14051 |